What is he best known for?
The fields of study he is best known for:
His primary areas of study are Biochemistry, Molecular biology, ADAM17 Protein, Peptide sequence and Erythropoietin-producing hepatocellular receptor.
Douglas P. Cerretti has researched Molecular biology in several fields, including Receptor, Transfection and Monocyte.
The ADAM17 Protein study combines topics in areas such as ADAM15, ADAM Proteins and ADAM9.
His studies deal with areas such as ADAM28, Ectodomain and ADAM8 as well as ADAM15.
His Peptide sequence research focuses on Complementary DNA and how it relates to Cleavage, NS2-3 protease and Protease.
His studies in Erythropoietin-producing hepatocellular receptor integrate themes in fields like Receptor Protein-Tyrosine Kinases and Ephrin.
His most cited work include:
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells (2698 citations)
- Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs (1446 citations)
- An Essential Role for Ectodomain Shedding in Mammalian Development (1424 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Molecular biology, Biochemistry, Cell biology, Erythropoietin-producing hepatocellular receptor and Complementary DNA.
His Molecular biology study combines topics from a wide range of disciplines, such as Peptide sequence, Gene, Recombinant DNA, DNA and Receptor.
Biochemistry is closely attributed to Antigen binding in his work.
His work deals with themes such as Neuroscience and Ephrin, which intersect with Erythropoietin-producing hepatocellular receptor.
Douglas P. Cerretti studied Complementary DNA and Amino acid that intersect with Bone marrow.
His ADAM17 Protein research integrates issues from ADAM15, Sheddase, ADAM Proteins, ADAM10 and ADAM9.
He most often published in these fields:
- Molecular biology (50.00%)
- Biochemistry (23.81%)
- Cell biology (22.22%)
What were the highlights of his more recent work (between 2002-2013)?
- Cell biology (22.22%)
- Erythropoietin-producing hepatocellular receptor (22.22%)
- Biochemistry (23.81%)
In recent papers he was focusing on the following fields of study:
Douglas P. Cerretti focuses on Cell biology, Erythropoietin-producing hepatocellular receptor, Biochemistry, Nucleic acid and Antigen binding.
The concepts of his Cell biology study are interwoven with issues in Receptor-mediated endocytosis and Dynamin.
His work carried out in the field of Erythropoietin-producing hepatocellular receptor brings together such families of science as Neural development, Synaptogenesis, Nucleus and Ephrin.
His Biochemistry study incorporates themes from Molecular biology and Antibody.
His Antibody research incorporates elements of Tumor necrosis factor alpha, Cell, Protease, Complementary DNA and Metalloproteinase.
As part of the same scientific family, he usually focuses on Nucleic acid, concentrating on Binding protein and intersecting with Monocyte.
Between 2002 and 2013, his most popular works were:
- An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation (324 citations)
- EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis. (97 citations)
- Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. (93 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Monocyte, Cell biology, Signal transduction, Receptor tyrosine kinase and Angiogenesis.
His Monocyte study combines topics in areas such as Antigen binding, Binding protein and Nucleic acid.
His study in Adaptor Signaling Protein, MAPK/ERK pathway, SH3 domain, Tyrosine phosphorylation and Proto-oncogene tyrosine-protein kinase Src falls under the purview of Cell biology.
His Signal transduction research is multidisciplinary, incorporating perspectives in Vascular endothelial growth factor A, Tumor progression and Receptor.
His study in Angiogenesis is interdisciplinary in nature, drawing from both Retina, Retinal and Gelatinase.
His Cancer research study integrates concerns from other disciplines, such as Endothelium, Angiopoietins and Angiopoietin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
